Cargando…

Long-Term Resolution of Perifoveal Exudative Vascular Anomalous Complex after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor

Perifoveal exudative vascular anomalous complex (PEVAC) is a perifoveal aneurysmal vascular lesion found in healthy subjects. A 68-year-old woman was diagnosed with a typical unilateral and unifocal PEVAC lesion after extensive multimodal imaging and was treated with three-monthly intravitreal injec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torrell-Belzach, Nuria, Miere, Alexandra, Souied, Eric, Cohen, Salomon Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710424/ https://www.ncbi.nlm.nih.gov/pubmed/36466064 http://dx.doi.org/10.1159/000526991

Ejemplares similares

Atypical case of perifoveal exudative vascular anomalous complex associated with pachychoroid pigment epitheliopathy
por: Herda, Nabil, et al.
Publicado: (2022)

Long-term follow-up of perifoveal exudative vascular anomalous complex treated with intravitreal injections of anti-vascular endothelial growth factor and thermal laser photocoagulation
por: Corvi, Federico, et al.
Publicado: (2020)

Perifoveal exudative vascular anomalous complex in a highly myopic eye
por: Sacconi, Riccardo, et al.
Publicado: (2020)

Atypical perifoveal exudative vascular anomalous complex (PEVAC) with multifocal and bilateral presentation
por: Fernández-Vigo, José Ignacio, et al.
Publicado: (2020)

Multimodal imaging comparison of perifoveal exudative vascular anomalous complex and resembling lesions
por: Smid, Lisette M., et al.
Publicado: (2020)

Progressive resolution of exudation from perifoveal vascular anomalous complex: A possible role of diclofenac therapy?
por: Tombolini, Beatrice, et al.
Publicado: (2022)

Lamellar hole-associated epiretinal proliferation presenting with perifoveal exudative vascular anomalous complex
por: Siedlecki, Jakob, et al.
Publicado: (2019)

Case Report: A Case of Perifoveal Exudative Vascular Anomalous Complex With a Good Prognosis
por: Fu, Min, et al.
Publicado: (2021)

MULTIPLE-SESSION SUBTHRESHOLD MICROPULSE LASER THERAPY FOR EXUDATIVE PERIFOVEAL VASCULAR ANOMALOUS COMPLEX: A CASE REPORT
por: Kang, Yong Koo, et al.
Publicado: (2023)

Response to treatment with intravitreal anti-vascular endothelial growth factors in bilateral exudative cuticular drusen
por: Durlu, Yusuf K.
Publicado: (2021)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline
por: Nikkhah, Homayoun, et al.
Publicado: (2018)

Intravitreal injections during COVID-19 outbreak: Protective measures, total duration of care and perceived quality of care in a tertiary retina center
por: Denys, Paul, et al.
Publicado: (2021)

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
por: Rai, Bhim Bahadur, et al.
Publicado: (2023)

INTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY
por: Lyu, Jiao, et al.
Publicado: (2021)

Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual Acuity
por: Chang, Young Suk, et al.
Publicado: (2014)

Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach
por: Petri, Anne-Sofie, et al.
Publicado: (2020)

AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE–RELATED MACULAR DEGENERATION: The ARI2 Study
por: Blanco-Garavito, Rocio, et al.
Publicado: (2018)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão, Miguel, et al.
Publicado: (2017)

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
por: Labardini, Cecilia P., et al.
Publicado: (2018)

Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection
por: Kaya, Mahmut, et al.
Publicado: (2021)

Intravitreal anti-vascular endothelial growth factor injections to treat post-trabeculectomy Swan syndrome
por: Feu-Basilio, Silvia, et al.
Publicado: (2022)

Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
por: Wang, Donghyun, et al.
Publicado: (2014)

Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy
por: Kianersi, Farzan, et al.
Publicado: (2021)

Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas
por: Lee, Jung Pil, et al.
Publicado: (2016)

Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review
por: Merani, Rohan, et al.
Publicado: (2015)

Incidence of Endophthalmitis after Intravitreal Anti-Vascular Endothelial Growth Factor Injections in an Operating Room in China
por: Chen, Yanyun, et al.
Publicado: (2020)

Nutritionally variant streptococci causing endophthalmitis associated with intravitreal anti-vascular endothelial growth factor injection
por: Steinmetz, Robert L., et al.
Publicado: (2021)

The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2023)

Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections
por: Savastano, Maria Cristina, et al.
Publicado: (2021)

Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
por: Takayama, Kei, et al.
Publicado: (2012)

Type 3 Neovascularization Associated with Retinitis Pigmentosa
por: Sayadi, Jihene, et al.
Publicado: (2017)

The Spectrum of Central Choriocapillaris Abnormalities on Swept-Source Optical Coherence Tomography Angiography in the Fellow Eye of Unilateral Exudative Age-Related Macular Degeneration Patients: From Flow Deficits to Subclinical Non-Exudative Neovascularization
por: Khorrami Kashi, Alexis, et al.
Publicado: (2021)

The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti–Vascular Endothelial Growth Factor Injections
por: Patel, Samir N., et al.
Publicado: (2021)

Hemodynamic and structural changes in retinal arterial macroaneurysm after intravitreal anti-vascular endothelial growth factor injection
por: Kadomoto, Shin, et al.
Publicado: (2021)

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
por: Taher, Nada O., et al.
Publicado: (2022)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
por: Hang, Abraham, et al.
Publicado: (2023)

Bilateral Macular Hole Related to Tamoxifen Low-Dose Toxicity
por: Torrell Belzach, Nuria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k36kceu5014a5o5ara17vn1bme